Biofilm-based central line-associated bloodstream infections

Advances in Experimental Medicine and Biology

Volumn 830, Issue , 2015, Pages 157-179

  Yousif, Ammar ^a   Jamal, Mohamed A ^a   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CHELATING AGENT; EDETIC ACID DERIVATIVE; MINOCYCLINE; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COLONY FORMING UNIT; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; HUMAN; INCIDENCE; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ADVERSE EFFECTS; BACTERIA; BLOOD; CANDIDA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; CLASSIFICATION; ELECTRON MICROSCOPY; GROWTH, DEVELOPMENT AND AGING; INDWELLING CATHETER; MICROBIAL CONSORTIUM; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; ULTRASTRUCTURE;

BACTERIA; BIOFILMS; CANDIDA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; HUMANS; MICROBIAL CONSORTIA; MICROSCOPY, ELECTRON;

EID: 84926632533     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-11038-7_10     Document Type: Article

References (218)

1. Adair CG, Gorman SP, Feron BM, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, Webb CH, Mccarthy GJ, Milligan KR (1999) Implications of endotracheal tube biofi lm for ventilator- associated pneumonia. Intensive Care Med 25:1072-1076
2. Adam B, Baillie GS, Douglas LJ (2002) Mixed species biofi lms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 51:344-349
3. Agladze K, Wang X, Romeo T (2005) Spatial periodicity of Escherichia coli K-12 biofi lm microstructure initiates during a reversible, polar attachment phase of development and requires the polysaccharide adhesin PGA. J Bacteriol 187:8237-8246
4. Al-Fattani MA, Douglas LJ (2006) Biofi lm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55:999-1008
5. Alipour M, Suntres ZE, Omri A (2009) Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother 64:317-325
6. Allison DG, Ruiz B, SanJose C, Jaspe A, Gilbert P (1998) Extracellular products as mediators of the formation and detachment of Pseudomonas fl uorescens biofi lms. FEMS Microbiol Lett 167:179-184
7. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I (1995) Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 14:134-137
8. Ardehali R, Shi L, Janatova J, Mohammad SF, Burns GL (2002) The effect of apo-transferrin on bacterial adhesion to biomaterials. Artif Organs 26:512-520
9. Bach A, Schmidt H, Bottiger B, Schreiber B, Bohrer H, Motsch J, Martin E, Sonntag HG (1996) Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 37:315-322
10. Banin E, Vasil ML, Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofi lm formation. Proc Natl Acad Sci U S A 102:11076-11081
11. Barraud N, Hassett DJ, Hwang SH, Rice SA, Kjelleberg S, Webb JS (2006) Involvement of nitric oxide in biofi lm dispersal of Pseudomonas aeruginosa. J Bacteriol 188:7344-7353
12. Baumgartner JN, Cooper SL (1998) Infl uence of thrombus components in mediating Staphylococcus aureus adhesion to polyurethane surfaces. J Biomed Mater Res 40:660-670
13. Beckingsale TB, Page JE, Jennings A, Fawcett T (2011) Increased sodium and potassium concentrations lead to increased penicillin resistance and increased biofi lm formation in Stapylococcus aureus. J Bone Joint Surg Br 93-B:319
14. Beloin C, Roux A, Ghigo JM (2008) Escherichia coli biofi lms. Curr Top Microbiol Immunol 322:249-289
15. Betjes MG, Van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidinecontaining lock solution. Nephrol Dial Transplant 19:1546-1551
16. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE (1982) Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 92:720-727
17. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ (2005) A randomized, controlled trial of a new vascular catheter fl ush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520-524
18. Boles BR, Horswill AR (2008) Agr-mediated dispersal of Staphylococcus aureus biofi lms. PLoS Pathog 4:e1000052
19. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ (2009) Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 43:210-219
20. Boyd A, Chakrabarty AM (1994) Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 60:2355-2359
21. Branda SS, Vik S, Friedman L, Kolter R (2005) Biofi lms: the matrix revisited. Trends Microbiol 13:20-26
22. Brogden KA, Guthmiller JM, Taylor CE (2005) Human polymicrobial infections. Lancet 365:253-255
23. Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I (2011) Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect 17:1711-1716
24. Campos RP, Do Nascimento MM, Chula DC, Riella MC (2011) Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939-1945
25. Casanova Vivas S (2014) Recommendations from CDC for the prevention of catheter-related infections (2013 update). Rev Enferm 37:28-33
26. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6:17-27
27. Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ (2009) Smallmolecule inhibitors target Escherichia coli amyloid biogenesis and biofi lm formation. Nat Chem Biol 5:913-919
28. Centers for Disease Control and Prevention (2011) Vital signs: central line-associated blood stream infections - United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 60:243-248
29. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R, Hachem R, Raad I (2003) Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36:116-119
30. Chen H, Fujita M, Feng Q, Clardy J, Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A 101:5048-5052
31. Christner M, Franke GC, Schommer NN, Wendt U, Wegert K, Pehle P, Kroll G, Schulze C, Buck F, Mack D, Aepfelbacher M, Rohde H (2010) The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofi lm accumulation and attachment to fi bronectin. Mol Microbiol 75:187-207
32. Cicalini S, Palmieri F, Noto P, Boumis E, Petrosillo N (2002) Diagnosis of intra vascular catheter-related infection. J Vasc Access 3:114-119
33. Cleri DJ, Corrado ML, Seligman SJ (1980) Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 141:781-786
34. Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, Pruett TL, Schwenzer KJ, Farr BM (1992) A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 327:1062-1068
35. Cookson AL, Cooley WA, Woodward MJ (2002) The role of type 1 and curli fi mbriae of Shiga toxin-producing Escherichia coli in adherence to abiotic surfaces. Int J Med Microbiol 292:195-205
36. Costerton JW (1995) Overview of microbial biofi lms. J Ind Microbiol 15:137-140
37. Costerton JW, Irvin RT, Cheng KJ (1981) The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 35:299-324
38. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ (1987) Bacterial biofi lms in nature and disease. Annu Rev Microbiol 41:435-464
39. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofi lms: a common cause of persistent infections. Science 284:1318-1322
40. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F (1999) The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofi lm formation. Infect Immun 67:5427-5433
41. Danese PN, Pratt LA, Dove SL, Kolter R (2000a) The outer membrane protein, antigen 43, mediates cell-tocell interactions within Escherichia coli biofi lms. Mol Microbiol 37:424-432
42. Danese PN, Pratt LA, Kolter R (2000b) Exopolysaccharide production is required for development of Escherichia coli K-12 biofi lm architecture. J Bacteriol 182:3593-3596
43. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340:1-8
44. Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II (2005) Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 242:193-200
45. Das T, Sehar S, Koop L, Wong YK, Ahmed S, Siddiqui KS, Manefi eld M (2014) Infl uence of calcium in extracellular DNA mediated bacterial aggregation and biofi lm formation. PLoS One 9:e91935
46. Davey ME, Caiazza NC, O’Toole GA (2003) Rhamnolipid surfactant production affects biofi lm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185:1027-1036
47. Davies DG, Marques CN (2009) A fatty acid messenger is responsible for inducing dispersion in microbial biofi lms. J Bacteriol 191:1393-1403
48. Decho AW (2010) Overview of biopolymer-induced mineralization: what goes on in biofi lms? Ecol Eng 36:137-144
49. Dickinson RB, Nagel JA, Mcdevitt D, Foster TJ, Proctor RA, Cooper SL (1995) Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fi brinogen under fl ow. Infect Immun 63:3143-3150
50. Dickinson RB, Nagel JA, Proctor RA, Cooper SL (1997) Quantitative comparison of shear-dependent Staphylococcus aureus adhesion to three polyurethane ionomer analogs with distinct surface properties. J Biomed Mater Res 36:152-162
51. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA (2001) Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136:229-234
52. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted fi lling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133-2139
53. Donlan RM (2002) Biofi lms: microbial life on surfaces. Emerg Infect Dis 8:881-890
54. Donlan RM, Costerton JW (2002) Biofi lms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193
55. Downes KJ, Metlay JP, Bell LM, Mcgowan KL, Elliott MR, Shah SS (2008) Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis 46:387-394
56. Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips I (1991) Infective complications associated with the use of the Quinton ‘Permcath’ for long-term central vascular access in haemodialysis. J Hosp Infect 19:257-262
57. Dunne WM Jr (2002) Bacterial adhesion: seen any good biofi lms lately? Clin Microbiol Rev 15:155-166
58. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC (2009) National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 37:783-805
59. El-Azizi MA, Starks SE, Khardori N (2004) Interactions of Candida albicans with other Candida spp. and bacteria in the biofi lms. J Appl Microbiol 96:1067-1073
60. Federle MJ, Bassler BL (2003) Interspecies communication in bacteria. J Clin Invest 112:1291-1299
61. Feely T, Copley A, Bleyer AJ (2007) Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am J Nephrol 27:24-29
62. Flemming HC, Wingender J (2010) The biofi lm matrix. Nat Rev Microbiol 8:623-633
63. Fujita S, Sumita S, Kawana S, Iwasaki H, Namiki A (1997) Two cases of anaphylactic shock induced by chlorhexidine. Masui 46:1118-1121
64. Geoghegan JA, Corrigan RM, Gruszka DT, Speziale P, O’Gara JP, Potts JR, Foster TJ (2010) Role of surface protein SasG in biofi lm formation by Staphylococcus aureus. J Bacteriol 192:5663-5673
65. Gjermansen M, Ragas P, Sternberg C, Molin S, Tolker-Nielsen T (2005) Characterization of starvationinduced dispersion in Pseudomonas putida biofi lms. Environ Microbiol 7:894-906
66. Goetz AM, Wagener MM, Miller JM, Muder RR (1998) Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19:842-845
67. Gotz F (2002) Staphylococcus and biofi lms. Mol Microbiol 43:1367-1378
68. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fi brosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539-574
69. Granger BL, Flenniken ML, Davis DA, Mitchell AP, Cutler JE (2005) Yeast wall protein 1 of Candida albicans. Microbiology 151:1631-1644
70. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofi lms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95-108
71. Hancock LE, Perego M (2004) The Enterococcus faecalis fsr two-component system controls biofi lm development through production of gelatinase. J Bacteriol 186:5629-5639
72. Hanna HA, Raad II, Hackett B, Wallace SK, Price KJ, Coyle DE, Parmley CL, MD Anderson Catheter Study Group (2003) Antibiotic-impregnated catheters associated with signifi cant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 124:1030-1038
73. Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfi eld P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I (2004) Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheterrelated bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22:3163-3171
74. Harriott MM, Noverr MC (2010) Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofi lm formation. Antimicrob Agents Chemother 54:3746-3755
75. Hawser SP, Douglas LJ (1995) Resistance of Candida albicans biofi lms to antifungal agents in vitro. Antimicrob Agents Chemother 39:2128-2131
76. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M, Parsek MR (2001) Alginate overproduction affects Pseudomonas aeruginosa biofi lm structure and function. J Bacteriol 183:5395-5401
77. Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, Peters G, Waldvogel FA (1988) Fibronectin, fi brinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 158:693-701
78. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofi lms. Int J Antimicrob Agents 35:322-332
79. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance defi nition of health care-associated infection and criteria for specifi c types of infections in the acute care setting. Am J Infect Control 36:309-332
80. Huang YH, Ferrieres L, Clarke DJ (2006) The role of the Rcs phosphorelay in Enterobacteriaceae. Res Microbiol 157:206-212
81. Hughes KA, Sutherland IW, Jones MV (1998) Biofi lm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144(Pt 11):3039-3047
82. Hunt SM, Werner EM, Huang B, Hamilton MA, Stewart PS (2004) Hypothesis for the role of nutrient starvation in biofi lm detachment. Appl Environ Microbiol 70:7418-7425
83. Isberg RR, Barnes P (2002) Dancing with the host; fl owdependent bacterial adhesion. Cell 110:1-4
84. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H (1984) Pseudomonas cepacia infection in cystic fi brosis: an emerging problem. J Pediatr 104:206-210
85. Izano EA, Amarante MA, Kher WB, Kaplan JB (2008) Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofi lms. Appl Environ Microbiol 74:470-476
86. Jackson DW, Suzuki K, Oakford L, Simecka JW, Hart ME, Romeo T (2002) Biofi lm formation and dispersal under the infl uence of the global regulator CsrA of Escherichia coli. J Bacteriol 184:290-301
87. Jamal MA Jr, Jiang Y, Hachem R, Chaftari A-M, Raad II (2014) Prevention of transmission of multidrugresistant organisms during catheter exchange using antimicrobial catheters. Antimicrob Agents Chemother 58:5291-5296
88. Kaplan JB (2010) Biofi lm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J Dent Res 89:205-218
89. Karatan E, Watnick P (2009) Signals, regulatory networks, and materials that build and break bacterial biofi lms. Microbiol Mol Biol Rev 73:310-347
90. Katsikogianni M, Missirlis YF (2004) Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteria-material interactions. Eur Cell Mater 8:37-57
91. Kemp KD, Singh KV, Nallapareddy SR, Murray BE (2007) Relative contributions of Enterococcus faecalis OG1RF sortase-encoding genes, srtA and bps (srtC), to biofi lm formation and a murine model of urinary tract infection. Infect Immun 75:5399-5404
92. Khajanchi BK, Kozlova EV, Sha J, Popov VL, Chopra AK (2012) The two-component QseBC signalling system regulates in vitro and in vivo virulence of Aeromonas hydrophila. Microbiology 158:259-271
93. Kierek K, Watnick PI (2003) The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca2 +-dependent biofi lm development in sea water. Proc Natl Acad Sci U S A 100:14357-14362
94. Kinane DF, Riggio MP, Walker KF, Mackenzie D, Shearer B (2005) Bacteraemia following periodontal procedures. J Clin Periodontol 32:708-713
95. Kite P, Eastwood K, Sugden S, Percival SL (2004) Use of in vivo-generated biofi lms from hemodialysis catheters to test the effi cacy of a novel antimicrobial catheter lock for biofi lm eradication in vitro. J Clin Microbiol 42:3073-3076
96. Klapper I, Rupp CJ, Cargo R, Purvedorj B, Stoodley P (2002) Viscoelastic fl uid description of bacterial biofi lm material properties. Biotechnol Bioeng 80:289-296
97. Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T (2003) Biofi lm formation by Pseudomonas aeruginosa wild type, fl agella and type IV pili mutants. Mol Microbiol 48:1511-1524
98. Kline KA, Dodson KW, Caparon MG, Hultgren SJ (2010) A tale of two pili: assembly and function of pili in bacteria. Trends Microbiol 18:224-232
99. Kong KF, Vuong C, Otto M (2006) Staphylococcus quorum sensing in biofi lm formation and infection. Int J Med Microbiol 296:133-139
100. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ (2009) QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 73:1020-1031
101. Kostakioti M, Hadjifrangiskou M, Hultgren SJ (2013) Bacterial biofi lms: development, dispersal, and thera-peutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 3:a010306
102. Kristinsson KG, Burnett IA, Spencer RC (1989) Evaluation of three methods for culturing long intravascular catheters. J Hosp Infect 14:183-191
103. LASA I, PENADES JR (2006) Bap: a family of surface proteins involved in biofi lm formation. Res Microbiol 157:99-107
104. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK (2005) The exopolysaccharide alginate protects Pseudomonas aeruginosa biofi lm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175:7512-7518
105. Lewis K (2001) Riddle of biofi lm resistance. Antimicrob Agents Chemother 45:999-1007
106. Li F, Palecek SP (2008) Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cellsubstrate interactions. Microbiology 154:1193-1203
107. Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R (1985) Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 21:357-360
108. Lyte M, Freestone PP, Neal CP, Olson BA, Haigh RD, Bayston R, Williams PH (2003) Stimulation of Staphylococcus epidermidis growth and biofi lm formation by catecholamine inotropes. Lancet 361:130-135
109. Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257-266
110. Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159-1171
111. Ma L, Wang S, Wang D, Parsek MR, Wozniak DJ (2012) The roles of biofi lm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofi lms. FEMS Immunol Med Microbiol 65:377-380
112. Mann EE, Wozniak DJ (2012) Pseudomonas biofi lm matrix composition and niche biology. FEMS Microbiol Rev 36:893-916
113. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, Tsang LH, Smeltzer MS, Horswill AR, Bayles KW (2009) Modulation of eDNA release and degradation affects Staphylococcus aureus biofi lm maturation. PLoS One 4:e5822
114. Marks LR, Davidson BA, Knight PR, Hakansson AP (2013) Interkingdom signaling induces Streptococcus pneumoniae biofi lm dispersion and transition from asymptomatic colonization to disease. MBio 4:e00438-13
115. Mathoera RB, Kok DJ, Nijman RJ (2000) Bladder calculi in augmentation cystoplasty in children. Urology 56:482-487
116. Mcdevitt D, Nanavaty T, House-Pompeo K, Bell E, Turner N, Mcintire L, Foster T, Hook M (1997) Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fi brinogen. Eur J Biochem 247:416-424
117. Mcgee DC, Gould MK (2003) Preventing complications of central venous catheterization. N Engl J Med 348:1123-1133
118. Mcintyre CW, Hulme LJ, Taal M, Fluck RJ (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801-805
119. Mehall JR, Saltzman DA, Jackson RJ, Smith SD (2002) Fibrin sheath enhances central venous catheter infection. Crit Care Med 30:908-912
120. Menzies BE (2003) The role of fi bronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 16:225-229
121. Mermel LA (2000) Prevention of intravascular catheterrelated infections. Ann Intern Med 132:391-402
122. Mohamed JA, Huang DB (2007) Biofi lm formation by enterococci. J Med Microbiol 56:1581-1588
123. Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE (2004) Infl uence of origin of isolates, especially endocarditis isolates, and various genes on biofi lm formation by Enterococcus faecalis. Infect Immun 72:3658-3663
124. Mohamed JA, Teng F, Nallapareddy SR, Murray BE (2006) Pleiotrophic effects of 2 Enterococcus faecalis sagA -like genes, salA and salB, which encode proteins that are antigenic during human infection, on biofi lm formation and binding to collagen type i and fi bronectin. J Infect Dis 193:231-240
125. Morgan R, Kohn S, Hwang SH, Hassett DJ, Sauer K (2006) BdlA, a chemotaxis regulator essential for biofi lm dispersion in Pseudomonas aeruginosa. J Bacteriol 188:7335-7343
126. Nallapareddy SR, Singh KV, Sillanpaa J, Garsin DA, Hook M, Erlandsen SL, Murray BE (2006) Endocarditis and biofi lm-associated pili of Enterococcus faecalis. J Clin Invest 116:2799-2807
127. Nett J, Lincoln L, Marchillo K, Andes D (2007a) Beta -1, 3 glucan as a test for central venous catheter biofi lm infection. J Infect Dis 195:1705-1712
128. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, Vanhandel M, Andes D (2007b) Putative role of beta-1, 3 glucans in Candida albicans biofi lm resistance. Antimicrob Agents Chemother 51:510-520
129. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ (1998) Clumping factor B (ClfB), a new surface-located fi brinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 30:245-257
130. Nobile CJ, Fox EP, Hartooni N, Mitchell KF, Hnisz D, Andes DR, Kuchler K, Johnson AD (2014) A histone deacetylase complex mediates biofi lm dispersal and drug resistance in Candida albicans. MBio 5:e01201-e01214
131. O’Gara JP (2007) ica and beyond: biofi lm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270:179-188
132. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, Mccormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 110:e51
133. O’Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, O’Gara JP (2007) Association between methicillin susceptibility and biofi lm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 45:1379-1388
134. O’Neill E, Pozzi C, Houston P, Humphreys H, Robinson DA, Loughman A, Foster TJ, O’Gara JP (2008) A novel Staphylococcus aureus biofi lm phenotype mediated by the fi bronectin-binding proteins, FnBPA and FnBPB. J Bacteriol 190:3835-3850
135. O’Toole GA, Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofi lm development. Mol Microbiol 30:295-304
136. O’Toole G, Kaplan HB, Kolter R (2000) Biofi lm formation as microbial development. Annu Rev Microbiol 54:49-79
137. Oda T, Hamasaki J, Kanda N, Mikami K (1997) Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter. Anesthesiology 87:1242-1244
138. Olson ME, Garvin KL, Fey PD, Rupp ME (2006) Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin Orthop Relat Res 451:21-24
139. Otto M (2014) Phenol-soluble modulins. Int J Med Microbiol 304:164-169
140. Pammi M, Liang R, Hicks J, Mistretta TA, Versalovic J (2013) Biofi lm extracellular DNA enhances mixed species biofi lms of Staphylococcus epidermidis and Candida albicans. BMC Microbiol 13:257
141. Paredes J, Alonso-Arce M, Schmidt C, Valderas D, Sedano B, Legarda J, Arizti F, Gomez E, Aguinaga A, Del Pozo JL, Arana S (2014) Smart central venous port for early detection of bacterial biofi lm related infections. Biomed Microdevices 16:365-374
142. Parsek MR, Singh PK (2003) Bacterial biofi lms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677-701
143. Pastar I, Nusbaum AG, Gil J, Patel SB, Chen J, Valdes J, Stojadinovic O, Plano LR, Tomic-Canic M, Davis SC (2013) Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One 8:e56846
144. Patrauchan MA, Sarkisova S, Sauer K, Franklin MJ (2005) Calcium infl uences cellular and extracellular product formation during biofi lm-associated growth of a marine Pseudoalteromonas sp. Microbiology 151:2885-2897
145. Patti JM, Allen BL, Mcgavin MJ, Hook M (1994) MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48:585-617
146. Pegues D, Axelrod P, Mcclarren C, Eisenberg BL, Hoffman JP, Ottery FD, Keidan RD, Boraas M, Weese J (1992) Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 49:156-162
147. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM (2005) Tetrasodium EDTA as a novel central venous catheter lock solution against biofi lm. Infect Control Hosp Epidemiol 26:515-519
148. Pereira AL, Silva TN, Gomes AC, Araujo AC, Giugliano LG (2010) Diarrhea-associated biofi lm formed by enteroaggregative Escherichia coli and aggregative Citrobacter freundii: a consortium mediated by putative F pili. BMC Microbiol 10:57
149. Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, Chatterjee SS, Cheung GY, Otto M (2012) How Staphylococcus aureus biofi lms develop their characteristic structure. Proc Natl Acad Sci U S A 109:1281-1286
150. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601
151. Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E, Gennaro R, Di Bonaventura G (2011) Antibacterial and anti-biofi lm effects of cathelicidin peptides against pathogens isolated from cystic fi brosis patients. Peptides 32:1807-1814
152. Potter A, Ceotto H, Giambiagi-Demarval M, Dos Santos KR, Nes IF, Bastos Mdo C (2009) The gene bap, involved in biofi lm production, is present in Staphylococcus spp. strains from nosocomial infections. J Microbiol 47:319-326
153. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355:2725-2732
154. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, Qu D (2007) Role of autolysin-mediated DNA release in biofi lm formation of Staphylococcus epidermidis. Microbiology 153:2083-2092
155. Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T (2009) Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofi lms produced by Staphylococcus epidermidis. Microbiology 155:2148-2156
156. Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893-898
157. Raad I, Bodey GP Sr (2011) Novel antimicrobial catheter lock solution: a new direction in which chelators replace heparin. Crit Care Med 39:875-876
158. Raad II, Hanna HA (2002) Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162:871-878
159. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407
160. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP (1996) The broad-spectrum activity and effi cacy of catheters coated with minocycline and rifampin. J Infect Dis 173:418-424
161. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C (1997) Central venous catheters coated with minocycline and rifampin for the prevention of catheterrelated colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127:267-274
162. Raad I, Hachem R, Tcholakian RK, Sherertz R (2002) Effi cacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46:327-332
163. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W (2003) In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofi lm on catheter surfaces. Antimicrob Agents Chemother 47:3580-3585
164. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R (2007) Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofi lm. Antimicrob Agents Chemother 51:78-83
165. Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R (2008a) The role of chelators in preventing biofi lm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21:385-392
166. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R (2008b) Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother 62:746-750
167. Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY (2012) Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56:935-941
168. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of fungal biofi lms. Crit Rev Microbiol 35:340-355
169. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162:1027-1030
170. Rendueles O, Kaplan JB, Ghigo JM (2013) Antibiofi lm polysaccharides. Environ Microbiol 15:334-346
171. Rice SA, Mcdougald D, Kumar N, Kjelleberg S (2005) The use of quorum-sensing blockers as therapeutic agents for the control of biofi lm-associated infections. Curr Opin Investig Drugs 6:178-184
172. Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887-892
173. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS (2003) Bacterial coaggregation: an integral process in the development of multi-species biofi lms. Trends Microbiol 11:94-100
174. Riedel K, Hentzer M, Geisenberger O, Huber B, Steidle A, Wu H, Hoiby N, Givskov M, Molin S, Eberl L (2001) N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofi lms. Microbiology 147:3249-3262
175. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, Knobloch JK, Ragunath C, Kaplan JB, Mack D (2007) Polysaccharide intercellular adhesin or protein factors in biofi lm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28:1711-1720
176. Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II (2013) Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofi lm organisms. Antimicrob Agents Chemother 57:3555-3560
177. Ruesch S, Walder B, Tramer MR (2002) Complications of central venous catheters: internal jugular versus subclavian access - a systematic review. Crit Care Med 30:454-460
178. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sherertz R (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143:570-580
179. Ryan RP, Fouhy Y, Garcia BF, Watt SA, Niehaus K, Yang L, Tolker-Nielsen T, Dow JM (2008) Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor infl uences biofi lm formation and polymyxin tolerance in Pseudomonas aeruginosa. Mol Microbiol 68:75-86
180. Sadovskaya I, Vinogradov E, Li J, Jabbouri S (2004) Structural elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus epidermidis RP62A, a reference biofi lm-positive strain. Carbohydr Res 339:1467-1473
181. Safdar N, Maki DG (2002) Infl ammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30:2632-2635
182. Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ (2005) Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofi lms. J Bacteriol 187:4327-4337
183. Sauer K, Cullen MC, Rickard AH, Zeef LA, Davies DG, Gilbert P (2004) Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofi lm. J Bacteriol 186:7312-7326
184. Shanks RM, Sargent JL, Martinez RM, Graber ML, O’Toole GA (2006) Catheter lock solutions infl uence staphylococcal biofi lm formation on abiotic surfaces. Nephrol Dial Transplant 21:2247-2255
185. Shenkman B, Varon D, Tamarin I, Dardik R, Peisachov M, Savion N, Rubinstein E (2002) Role of agr (RNAIII) in Staphylococcus aureus adherence to fi brinogen, fi bronectin, platelets and endothelial cells under static and fl ow conditions. J Med Microbiol 51:747-754
186. Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL (1990) Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28:76-82
187. Shih PC, Huang CT (2002) Effects of quorum-sensing defi ciency on Pseudomonas aeruginosa biofi lm formation and antibiotic resistance. J Antimicrob Chemother 49:309-314
188. Siegman-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM (1997) Diagnosis of vascular catheter-related bloodstream infection: a metaanalysis. J Clin Microbiol 35:928-936
189. Sillankorva S, Oliveira R, Vieira MJ, Sutherland IW, Azeredo J (2004) Bacteriophage Phi S1 infection of Pseudomonas fl uorescens planktonic cells versus biofi lms. Biofouling 20:133-138
190. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF (2010) Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 78:4644-4652
191. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofi lm development. Nature 417:552-555
192. Slobbe L, El Barzouhi A, Boersma E, Rijnders BJ (2009) Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. J Clin Microbiol 47:885-888
193. Song B, Leff LG (2006) Infl uence of magnesium ions on biofi lm formation by Pseudomonas fl uorescens. Microbiol Res 161:355-361
194. Soufi r L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S (1999) Attributable morbidity and mortality of catheter- related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20:396-401
195. Steinberger RE, Holden PA (2005) Extracellular DNA in single- and multiple-species unsaturated biofi lms. Appl Environ Microbiol 71:5404-5410
196. Stoodley P, Lewandowski Z, Boyle JD, Lappin-Scott HM (1999) Structural deformation of bacterial biofi lms caused by short-term fl uctuations in fl uid shear: an in situ investigation of biofi lm rheology. Biotechnol Bioeng 65:83-92
197. Sutherland IW (1983) Microbial exopolysaccharides - their role in microbial adhesion in aqueous systems. Crit Rev Microbiol 10:173-201
198. Sutherland IW (2001) The biofi lm matrix-an immobilized but dynamic microbial environment. Trends Microbiol 9:222-227
199. Sutherland IW, Hughes KA, Skillman LC, Tait K (2004) The interaction of phage and biofi lms. FEMS Microbiol Lett 232:1-6
200. Sutter D, Stagliano D, Braun L, Williams F, Arnold J, Ottolini M, Epstein J (2008) Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management. Pediatr Infect Dis J 27:400-405
201. Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Hook M (1993) A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 7:99-107
202. Thomas VC, Thurlow LR, Boyle D, Hancock LE (2008) Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases infl uences biofi lm development. J Bacteriol 190:5690-5698
203. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, Sun TT, Schaeffer AJ, Klumpp DJ (2009) Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5:e1000415
204. Uhlich GA, Cooke PH, Solomon EB (2006) Analyses of the red-dry-rough phenotype of an Escherichia coli O157: H7 strain and its role in biofi lm formation and resistance to antibacterial agents. Appl Environ Microbiol 72:2564-2572
205. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233-3244
206. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL (2010) The transcriptional regulator Nrg1p controls Candida albicans biofi lm formation and dispersion. Eukaryot Cell 9:1531-1537
207. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Effi cacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281:261-267
208. Wang X, Dubey AK, Suzuki K, Baker CS, Babitzke P, Romeo T (2005) CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofi lm polysaccharide adhesin of Escherichia coli. Mol Microbiol 56:1648-1663
209. Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, Queck SY, Otto M (2011) Staphylococcus epidermidis surfactant peptides promote biofi lm maturation and dissemination of biofi lm-associated infection in mice. J Clin Invest 121:238-248
210. Waters CM, Bassler BL (2005) Quorum sensing: cell-tocell communication in bacteria. Annu Rev Cell Dev Biol 21:319-346
211. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, Koch B, Givskov M, Kjelleberg S (2003) Cell death in Pseudomonas aeruginosa biofi lm development. J Bacteriol 185:4585-4592
212. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Slattegard R, Hernalsteens JP, Wyns L, Oscarson S, De Greve H, Hultgren S, Bouckaert J (2008) Intervening with urinary tract infections using anti- adhesives based on the crystal structure of the FimHoligomannose-3 complex. PLoS One 3:e2040
213. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS (2002) Extracellular DNA required for bacterial biofi lm formation. Science 295:1487
214. Wu Y, Outten FW (2009) IscR controls iron-dependent biofi lm formation in Escherichia coli by regulating type I fi mbria expression. J Bacteriol 191:1248-1257
215. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M, Tolker-Nielsen T (2007) Effects of iron on DNA release and biofi lm development by Pseudomonas aeruginosa. Microbiology 153:1318-1328
216. Yang L, Liu Y, Wu H, Hoiby N, Molin S, Song ZJ (2011) Current understanding of multi-species biofi lms. Int J Oral Sci 3:74-81
217. Yang L, Hengzhuang W, Wu H, Damkiaer S, Jochumsen N, Song Z, Givskov M, Hoiby N, Molin S (2012) Polysaccharides serve as scaffold of biofi lms formed by mucoid Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 65:366-376
218. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, Dekievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, Mcdermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ (2002) Pseudomonas aeruginosa anaerobic respiration in biofi lms: relationships to cystic fi brosis pathogenesis. Dev Cell 3:593-603